First Wave BioPharma Inc (NASDAQ: FWBI) shares are trading lower after the company received topline results from its Phase 2 SPAN trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic insufficiency in cystic fibrosis patients. Initial data from the study indicate the enhanced adrulipase formulation was safe and well tolerated and demonstrated an improvement over prior formulations of adrulipase. However, the preliminary d
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from its Phase 2b FRONTIER 1 clinical trial.
BioXcel Therapeutics (BTAI) Announces Promising Topline Results from Part 1 of SERENITY III Trial of BXCL501 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- Over 50% of patients dosed across 20 active clinical sites - - On Track for Topline Results in late 2023 - Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed")